A detailed history of Maryland Capital Management transactions in Cryo Cell International Inc stock. As of the latest transaction made, Maryland Capital Management holds 19,563 shares of CCEL stock, worth $162,959. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,563
Previous 19,563 -0.0%
Holding current value
$162,959
Previous $115,000 3.48%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$8.97 - $14.16 $175,480 - $277,012
19,563 New
19,563 $237,000
Q4 2019

Feb 11, 2020

SELL
$7.13 - $8.9 $143,049 - $178,560
-20,063 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
20,063
20,063 $121,000

Others Institutions Holding CCEL

About CRYO CELL INTERNATIONAL INC


  • Ticker CCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 8,519,250
  • Market Cap $71M
  • Description
  • Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...
More about CCEL
Track This Portfolio

Track Maryland Capital Management Portfolio

Follow Maryland Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.